Forefront Lecture by Dr. Will Small

On Wednesday, October 5th the BC Centre for Excellence in HIV/AIDS will present a Forefront Lecture by Dr. Will Small called “Injection drug use and drug-related harm in Vancouver: Findings from a program of qualitative research.”

Will Small, Ph.D is a Qualitative Research Program Coordinator at the Urban Health Research Initiative, here at the British Columbia Centre for Excellence in HIV/AIDS. Dr. Small is also a Postdoctoral Fellow in the Department of Medicine at the University of British Columbia.

The talk will be from 12-1pm in the Hurlburt Auditorium at St. Paul’s Hospital.

A light lunch and refreshments will be served.

For more information, please contact Gina Willis at 604-806-9093, Ext. 69093.


Event Details

Days
Hours
Minutes
Seconds
Start Date
  • October 5, 2011 19:00
End Date
  • October 5, 2011 20:00
Email
education@bccfe.ca
Event Category
  • Lecture
Calendar of Events
Click here for the Calendar of Events
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search